Skip to main content
Erin Dean, MD, Internal Medicine, Gainesville, FL, UF Health Shands Hospital

ErinDeanMD

Internal Medicine Gainesville, FL

Hematology/Oncology

Physician

Dr. Dean is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dean's full profile

Already have an account?

  • Office

    UF Health Shands Cancer Hospital
    1515 SW Archer Rd
    Gainesville, FL 32610
    Phone+1 352-733-0972
    Fax+1 352-733-1269
  • Is this information wrong?

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2017 - 2020
  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Internal Medicine, 2014 - 2017
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2014

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Central nervous system manifestations as initial presentation of plasma cell disorders: Differential management of 3 cases based on disease extent  
    Kyle McGrath, Graeme A. Fenton, Robert P. Seifert, Keith R. Peters, John W. Hiemenz, Erin A. Dean, Current Problems in Cancer: Case Reports, 9/2023

Abstracts/Posters

  • Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-...
    Erin Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Association of high baseline metabolic tumor volume with response following axicabtagene ciloleucel in refractory large B-cell lymphoma. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Hospital Affiliations